P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

August 2004

Features

Meeting Highlights

The 40th Annual Meeting of the American Society of Clinical Oncology

The author outlines recent advances in the treatment of cancers of the brain, breast, colon, prostate gland, lung, and blood.
Lawrence M. Prescott, PhD

Increased Costs of Diabetes Therapy Not Related to Glycemic Control at Three Veterans Affairs Medical Outpatient Clinics

In the authors’ study of more than 4,000 veterans with diabetes, prescribing patterns, monthly total costs, and control of blood glucose levels differed according to hospital site. The authors show the relationships between the type of primary care provider, the intensity of treatment, monthly medication costs, monthly total costs, and glycemic control.
Shawn L. Fultz, MD, MPH, C. Bernie Good, MD, MPH, Mary E. Kelley, MS, and Michael J. Fine, MD, MSc

Pharmaceutical-Approval Update

The author reviews a combination tablet for lowering cholesterol (Vytorin™™), a new use for botulinum toxin (Botox®) for severe underarm sweating, and levofloxacin (Levaquin®) for patients with multidrug-resistant strains of Streptococcus pneumoniae in community-acquired pneumonia.
Marvin M. Goldenberg, PhD, RPh, MS

Oral Linezolid as Alternative Therapy in Patients with Cellulitis Who Have Been Referred to an Infusion Center

Linezolid (Zyvox®), an oral antimicrobial agent, appears to be safe and effective for treating moderately severe cases of cellulitis.
Gary E. Stein, PharmD, Sharon Schooley, Vivek Kak, MD, and Daniel H. Havlichek, MD

Continuing Medical Education

Topical Treatment of Xeroderma Pigmentosum

Dr. Lin and Dr. English discuss some new approaches to the therapy for a rare skin condition.
Peggy Lin, MD, and Joseph C. English III, MD

Departments

Editorial

Second-Generation Antipsychotic Agents: A Classic P&T Committee Dilemma

David Nash, MD, MBA, explains how the adverse effects of second-generation (atypical) antipsychotic agents represent a conundrum for P&T committee members.
David Nash, MD, MBA

Medication Errors

Suggestions for Resolving Conflicts in Drug Therapy

Matthew Grissinger, RPh, FASCP, offers some solutions for resolving conflicts in drug therapy.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Luck of the Draw: Few Medicare Recipients to Get Maximum Help with Drug Costs

Stephen Barlas discusses a “drug lottery program,” part of the Medicare Modernization Act of 2003, which is intended to help some beneficiaries with their prescription drug costs.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Tiotropium Bromide for the Maintenance of Chronic Obstructive Pulmonary Disease

The authors review tiotropium bromide (Spiriva®) for the treatment of chronic obstructive pulmonary disease.
Michelle Levinzon, PharmD, and Larisa Chagan, BS, PharmD, BCPS